» Articles » PMID: 35071723

Beneficial Effects of Exercise on Chemotherapy-induced Peripheral Neuropathy and Sleep Disturbance: A Review of Literature and Proposed Mechanisms

Overview
Publisher Elsevier
Date 2022 Jan 24
PMID 35071723
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this narrative review is to evaluate the literature regarding exercise training as a therapy to prevent or mitigate deleterious side effects of chemotherapy, specifically peripheral neuropathy and sleep disturbances and to make concrete recommendations for implementation for the practicing oncologist. A literature search was conducted for studies that included an exercise intervention to be implemented for patients undergoing or previously treated with chemotherapy along with an analysis of its effect on either chemotherapy-induced peripheral neuropathy (CIPN) or chemotherapy-induced sleep disturbances. Studies were subsequently analyzed and summarized in order to determine the overall promise of exercise as a therapy in this setting. Five studies met inclusion criteria to be assessed with regard to the effect of exercise on CIPN and eight were included for sleep disturbances. Exercise was found to be a significantly beneficial therapy in preventing, mitigating, or improving the symptoms of CIPN and sleep disturbances in cancer patients in the majority of studies evaluated. Exercise is an effective intervention and should be specifically prescribed concurrently with chemotherapy to maximize potential of avoiding these debilitating side effects, which significantly and negatively impact quality of life in cancer survivors.

Citing Articles

Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy.

Celik A, Usta Yesilbalkan O Asia Pac J Oncol Nurs. 2024; 11(10):100581.

PMID: 39310727 PMC: 11416514. DOI: 10.1016/j.apjon.2024.100581.


Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model.

Lee K, Bulls H, Hoogland A, James B, Colon-Echevarria C, Jim H Cancers (Basel). 2024; 16(14).

PMID: 39061210 PMC: 11274737. DOI: 10.3390/cancers16142571.


Effects of Closed Kinetic Chain Exercises in Chemotherapy-Induced Peripheral Neuropathy: A Case Report.

Seth N, Raghuveer R, Qureshi M Cureus. 2024; 16(6):e62732.

PMID: 39036239 PMC: 11260115. DOI: 10.7759/cureus.62732.


Visual analysis of the research frontiers, hotspots and trends of exercise therapy intervention in tumor-related sleep-wake disorders.

Han J, Zhang J, Zhang L, Guo J, Peng X, Ying C Front Oncol. 2024; 14:1392844.

PMID: 38741781 PMC: 11089126. DOI: 10.3389/fonc.2024.1392844.


Efficacy of aerobic and resistance exercises on cancer pain: A meta-analysis of randomised controlled trials.

Austin P, Lee W, Costa D, Ritchie A, Lovell M Heliyon. 2024; 10(7):e29193.

PMID: 38623224 PMC: 11016720. DOI: 10.1016/j.heliyon.2024.e29193.


References
1.
Sandadi S, Frasure H, Broderick M, Waggoner S, Miller J, von Gruenigen V . The effect of sleep disturbance on quality of life in women with ovarian cancer. Gynecol Oncol. 2011; 123(2):351-5. DOI: 10.1016/j.ygyno.2011.07.028. View

2.
Courneya K, Sellar C, Trinh L, Forbes C, Stevinson C, McNeely M . A randomized trial of aerobic exercise and sleep quality in lymphoma patients receiving chemotherapy or no treatments. Cancer Epidemiol Biomarkers Prev. 2012; 21(6):887-94. DOI: 10.1158/1055-9965.EPI-12-0075. View

3.
Courneya K, Segal R, Mackey J, Gelmon K, Friedenreich C, Yasui Y . Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial. Breast Cancer Res Treat. 2014; 144(2):361-9. DOI: 10.1007/s10549-014-2883-0. View

4.
Ligibel J, Giobbie-Hurder A, Shockro L, Campbell N, Partridge A, Tolaney S . Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016; 122(8):1169-77. DOI: 10.1002/cncr.29899. View

5.
Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes H, Jahn P . Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020; 31(10):1306-1319. DOI: 10.1016/j.annonc.2020.07.003. View